David Weninger Barnes,Scott Louis Cohen,Dean Franklin Rigel
申请号：
US15281473
公开号：
US10112963B2
申请日:
2016.09.30
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides a compound of formula I；or a pharmaceutically acceptable salt thereof, wherein R1, R2 and R3 are defined herein. The invention also relates to a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides pharmaceutical composition of the compounds of the invention and a combination of pharmacologically active agents and a compound of the invention.
